A Lincoln nurse who specialises in looking after patients with blood disorders has been named Nurse of the Year. Alison ...

Hemlibra was found to ease pain and improve quality of life for hemophilia A patients, even those with long-term joint damage ...

Haemophilia, a rare blood disorder affecting clotting, is one such condition that can manifest early in life. It’s essential to understand haemophilia. Simply put, haemophilia is a condition ...

Gandhinagar: Haemophilia patients in Gujarat are receiving essential treatment to prevent life-threatening bleeding episodes, ...

Be Biopharma has secured $92m in a Series C financing round to advance its clinical programmes for haemophilia B and ...

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...

Haemophilia is a hereditary blood disorder characterised by a deficiency of certain coagulation factors, which can lead to life-threatening bleeding if left untreated. Why haemophilia A (with ...

Be Biopharma has secured $92m in a Series C financing round to advance its clinical programmes for haemophilia B and hypophosphatasia. New investor Nextech participated in the round, which also ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Tune into the latest EMJ Webinar, featuring five key members of the EAHAD, who discuss the EAHAD’s mission, aims, and key ...

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark COPENHAGEN, DENMARK—21 January 2025 — CSL Behring Denmark today announced that the first ...